{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:00:40Z","timestamp":1791918040490,"version":"4.3.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    Endometrial atypical hyperplasia\/endometrioid intraepithelial neoplasia (EAH\/EIN) is the acknowledged precursor of most endometrial carcinomas. Our aim was to assess the molecular alterations and the 4 specific molecular subtypes in EAH\/EIN diagnosed on endometrial biopsy. Forty EAH\/EIN biopsies were stained for estrogen receptor (ER), mismatch repair (MMR) proteins (PMS2 and MSH6), and p53 and were subjected to genomic testing (NGS Panel, Canexia Health V5). Based on these results, cases were assigned to 1 of 4 molecular subtypes [\n                    <jats:italic toggle=\"yes\">POLE<\/jats:italic>\n                    mut, MMRd, p53abn, and no specific molecular profile (NSMP)]. Follow-up data was collected. There was 1\n                    <jats:italic toggle=\"yes\">POLE<\/jats:italic>\n                    mut case with a pathogenic\n                    <jats:italic toggle=\"yes\">POLE<\/jats:italic>\n                    mutation (P286R), 5 were MMRd, 1 was p53abn, and the remaining 33 were NSMP. Thirty-nine of 40 cases harbored one or several mutations known to be associated with endometrial carcinoma pathogenesis (\n                    <jats:italic toggle=\"yes\">PIK3CA, PTEN<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">CTNNB1<\/jats:italic>\n                    ). On follow-up, there was carcinoma or EAH identified in a subsequent hysterectomy or biopsy in 6 of 6 patients with MMRd or p53abn EAH, compared with 19 of 34 with NSMP or\n                    <jats:italic toggle=\"yes\">POLE<\/jats:italic>\n                    mut (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.067). Most EAH\/EIN (33\/40, 81.5%) are of the NSMP molecular subtype. Molecular subtypes other than NSMP (eg,\n                    <jats:italic toggle=\"yes\">POLE<\/jats:italic>\n                    mutation, MMR deficiency, and p53 mutant pattern staining) are present in EAH\/EIN but are less common than in carcinoma. Mutations associated with EC pathogenesis were identified in 39\/40 (97.5%) biopsies containing EAH\/EIN, highlighting the neoplastic nature of this lesion and raising the possibility of using sequencing (NGS) as an adjuvant test to support a diagnosis of EAH\/EIN.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000001113","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T08:00:13Z","timestamp":1746777613000},"page":"120-128","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Molecular Subtype and Mutational Profile of Endometrial Atypical Hyperplasia\/Endometrioid Intraepithelial Neoplasia"],"prefix":"10.1097","volume":"45","author":[{"given":"Annamari","family":"Leino","sequence":"first","affiliation":[{"name":"Department of Pathology, Turku University Hospital, University of Turku, Turku"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Nostolahti","sequence":"additional","affiliation":[{"name":"Department of Pathology, Turku University Hospital, University of Turku, Turku"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ahtikoski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Turku University Hospital, University of Turku, Turku"},{"name":"Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-0877","authenticated-orcid":false,"given":"Jutta","family":"Huvila","sequence":"additional","affiliation":[{"name":"Department of Pathology, Turku University Hospital, University of Turku, Turku"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"R1-20260205","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20260205","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/PAS.0b013e31802ee494","article-title":"Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences","volume":"31","author":"Soslow","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R4-20260205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/modpathol.3880053","article-title":"Problems in the differential diagnosis of endometrial hyperplasia and carcinoma","volume":"13","author":"Silverberg","year":"2000","journal-title":"Mod Pathol"},{"key":"R5-20260205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.12249","article-title":"Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification","volume":"64","author":"Ordi","year":"2014","journal-title":"Histopathology"},{"key":"R6-20260205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.5608","article-title":"Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis","volume":"253","author":"Huvila","year":"2021","journal-title":"J Pathol"},{"key":"R7-20260205","doi-asserted-by":"crossref","first-page":"154278","DOI":"10.1016\/j.prp.2022.154278","article-title":"Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia","volume":"241","author":"Zhang","year":"2023","journal-title":"Pathol Res Pract"},{"key":"R8-20260205","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3390\/cancers13112847","article-title":"Molecular classification to prognosticate response in medically managed endometrial cancers and endometrial intraepithelial neoplasia","volume":"13","author":"Puechl","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R9-20260205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.humpath.2017.07.003","article-title":"Clonal evolution in paired endometrial intraepithelial neoplasia\/atypical hyperplasia and endometrioid adenocarcinoma","volume":"67","author":"Russo","year":"2017","journal-title":"Hum Pathol"},{"key":"R10-20260205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/path.5566","article-title":"Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma","volume":"253","author":"Li","year":"2021","journal-title":"J Pathol"},{"key":"R11-20260205","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.32822","article-title":"Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma","volume":"126","author":"Russo","year":"2020","journal-title":"Cancer"},{"key":"R12-20260205","first-page":"20","article-title":"Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors","volume":"254","author":"Aguilar","year":"2021","journal-title":"J Pathol"},{"key":"R13-20260205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/carcin\/bgx008","article-title":"Molecular profiles of benign and (pre)malignant endometrial lesions","volume":"38","author":"van der Putten","year":"2017","journal-title":"Carcinogenesis"},{"key":"R14-20260205","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/his.15029","article-title":"Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype","volume":"83","author":"Huvila","year":"2023","journal-title":"Histopathology"},{"key":"R15-20260205","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R16-20260205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2023.11.006","article-title":"Molecular subtyping in endometrial cancer: a promising strategy to guide fertility preservation","volume":"179","author":"Dagher","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R17-20260205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2019.06.012","article-title":"Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: towards early personalized patient management","volume":"154","author":"Abdulfatah","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R18-20260205","doi-asserted-by":"crossref","first-page":"370.e1","DOI":"10.1016\/j.ajog.2020.10.003","article-title":"Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer","volume":"224","author":"Chung","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20260205","doi-asserted-by":"crossref","first-page":"810631","DOI":"10.3389\/fonc.2022.810631","article-title":"Molecular classification in patients with endometrial cancer after fertility-preserving treatment: application of promise classifier and combination of prognostic evidence","volume":"12","author":"Ran","year":"2022","journal-title":"Front Oncol"},{"key":"R20-20260205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41379-018-0044-4","article-title":"Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance","volume":"31","author":"Niskakoski","year":"2018","journal-title":"Mod Pathol"},{"key":"R21-20260205","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e318202772e","article-title":"A proposed model for endometrial serous carcinogenesis","volume":"35","author":"Zheng","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R22-20260205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":"Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R23-20260205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00004347-200107000-00002","article-title":"Early uterine serous carcinoma: clonal origin of extrauterine disease","volume":"20","author":"Baergen","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R24-20260205","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","article-title":"Reliable identification of endometrial precancers through combined Pax2, \u03b2-catenin, and Pten immunohistochemistry","volume":"46","author":"Aguilar","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R25-20260205","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2353\/ajpath.2009.081085","article-title":"Molecular identification of \u201clatent precancers\u201d for endometrial serous carcinoma in benign-appearing endometrium","volume":"174","author":"Zhang","year":"2009","journal-title":"Am J Pathol"},{"key":"R26-20260205","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"R27-20260205","doi-asserted-by":"crossref","first-page":"678.e1","DOI":"10.1016\/j.ajog.2009.02.032","article-title":"Incidence of endometrial hyperplasia","volume":"200","author":"Reed","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20260205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2024.04.013","article-title":"Mismatch repair deficiency and abnormal p53 expression has significant predictive value for progesterone resistance and endometrial tumorigenesis in patients with endometrial atypical hyperplasia receiving fertility-preserving treatment","volume":"186","author":"Peng","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R29-20260205","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.3802\/jgo.2024.35.e27","article-title":"Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia","volume":"35","author":"Lv","year":"2024","journal-title":"J Gynecol Oncol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:01:00Z","timestamp":1770318060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001113","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}